CRA Roundtable: Opportunities and Challenges in Rare Diseases
As part of CRA’s issues leadership initiative to challenge industry thinking on rare diseases, we assembled a panel of CRA experts to discuss the opportunities...
Mr. Brubacher has 25 years of pharmaceutical and biotech commercialization experience and has led cross-functional marketing and commercial teams during the development and launch of pharmaceutical products.
His expertise includes global commercial planning and market strategy, analytics, market simulation, rare diseases, lifecycle management, launch planning, and competitive gaming. His time in industry spans multiple senior global strategic marketing and sales roles at companies such as Bayer, UCB, Vertex and Groupe Fournier, with a focus on orphan, immunology, and cardiovascular therapies in the US, Canada, and Europe.
Prior to joining CRA, Mr. Brubacher was Strategy Practice lead at C1 consulting for 6 years where he was responsible for client development, and leadership of consulting projects related to market strategy, commercial entry planning, geographic expansion, and system dynamics market simulation.